POINT Biopharma Global Inc. (PNT) Reports Q4 EPS of $1.53

POINT Biopharma Global Inc. (NASDAQ: PNT) reported Q4 EPS of $1.53, versus ($0.16) reported last year. Revenue for the quarter came in at $226.6 million, versus $0 reported last year.

For earnings history and earnings-related data on POINT Biopharma Global Inc. (PNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c